Form SCHEDULE 13G BioStem Technologies, Filed by: PNC FINANCIAL SERVICES GROUP, INC.
Alpha Vantage · StreetInsider · · AI-summarised by FinFlash
The PNC Financial Services Group, Inc. has filed a Schedule 13G form with the SEC regarding BioStem Technologies, Inc. This filing indicates that PNC beneficially owns 1,941,390 shares, representing 10.40% of the company's common stock. The shares are held in a fiduciary capacity by PNC Bank, National Association and PNC Ohio Trust Company for clients.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.